Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000234004 corresponds to a processed pseudogene similar to ribosomal protein S25 (RPS25). Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory elements. They do not encode functional proteins and play no known direct role as drug targets, disease drivers, or biomarkers in clinical practice. Their primary relevance may be as evolutionary relics or through very rare noncanonical regulatory functions (for example, if transcribed RNAs have regulatory effects), but no such role is described for this entry. Processed pseudogenes for ribosomal protein genes are common in the human genome due to the high expression of their parent genes, but they are generally regarded as biologically inert[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to ribosomal protein S25.